ACLY and cancer: Interestingly, the low citrate levels observed in malignant mesothelioma cells can be restored by microRNA-126 overexpression, a treatment which efficiently suppresses tumor growth, and inactivates ACLY and the insulin receptor substrate-1 (IRS-1)/Akt pathway [29].